Evidence Hub

Landscape of Liver Injury From Herbal and Dietary Supplements in Europe, Latin America, and Asia

R. Andrade

Clinical Liver Disease, 2019

3 citations

Abstract

• Herbal and dietary supplement hepatotoxicity (HILI) is scarcely reported in Europe and has a particular signature of hepatocellular pattern of liver injury, female sex predominance, and a greater severity compared with drug-induced liver injury (DILI) because of conventional medications. • In Latin America, preliminary unpublished data suggest that the relative prevalence of HILI with regard to DILI is greater than in Europe and the signature is similar. • In Asian countries, HILI, showing a similar signature than in the other continents, is the first cause of hepatotoxicity, except in India, despite the wide use of Ayurvedic medicine, although case series are increasingly being reported.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free